Gene expression profiling reveals cross-talk between melanoma and fibroblasts: Implications for host-tumor interactions in metastasis

Cancer Research

Volumn 65, Issue 10, 2005, Pages 4134-4146

  Gallagher, Paul G ^a   Bao, Yongde ^a   Prorock, Alyson ^a   Zigrino, Paola ^b   Nischt, Roswitha ^b   Politi, Vincenzo ^c   Mauch, Cornelia ^b   Dragulev, Bojan ^a   Fox, Jay William ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Polifarma SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE CXCL2; CXCL1 CHEMOKINE; FIBRILLAR COLLAGEN; INTERLEUKIN 11; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN; COCULTURE; DNA BINDING MOTIF; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION PROFILING; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; METASTASIS; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; UNINDEXED SEQUENCE; UPREGULATION;

CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION;

EID: 20144368873     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0415     Document Type: Article

References (50)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;240:860-7.
2. Wernert N. The multiple roles of tumour stroma. Virchows Arch 1997;430:433-43.
3. Fidler I. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 2002;3:1-6.
4. Tlsty TD. Stromal cells can contribute oncogenic signals. Cancer Biol 2001;11:97-104.
5. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial tumor cells. Differentiation 2002;70:486-97.
6. Brown LF, Guidi AJ, Schnitt SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
7. Radisky D, Muschler J, Bissell MJ. Order and disorder: the role of extracellular matrix in epithelial cancer. Cancer Invest 2002;20:139-53.
8. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
9. Lukashev ME, Werb Z. ECM signaling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998;8:437-41.
10. Thomasset N, Lochter A, Sympson CJ, et al. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol 1998;153:457-67.
11. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000;248:171-83.
12. Torisu H, Ono M, Kiryu H, et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFa and IL-1a. Int J Cancer 2000; 85:182-8.
13. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 2002;19:247-58.
14. Shih IM, Elder DE, Hsu MY, Herlyn M. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 1994;45:837-45.
15. Halaban R. Growth factors and melanomas. Semin Oncol 1996;23:673-81.
16. Van den Oord JJ, Paemen L, Opdenakker G, de Wolf-Peeters C. Expression of gelatinase B and extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997;151:665-70.
17. Kurschat P, Wickenhauser C, Groth W, et al. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. J Pathol 2002; 197:179-87.
18. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98: 31-6.
19. Donige SW, Salomonis N, Dahlquist KD, et al. MAPPFinder: using gene ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003;4:R7. Epub.
20. Dahlquist KD, Salomonis N, Vranizan K, et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002;31:19-20.
21. Sonesson B, Rosengren E, Hansson AS, Hansson C. UVB-induced inflammation gives increased d-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor. Exp Dermatol 2003;12:278-82.
22. Trepicchio WL, Wang L, Bozza M, Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J Immunol 1997; 159:5661-70.
23. Trepicchio W, Ozawa M, Walters IB, et al. Interleukin-11 selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 1999; 104:1527-37.
24. Parrinello S, Lin CQ, Murata K, et al. Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation and apoptosis. J Biol Chem 2001;276: 39213-9.
25. van Mujen GNP, Cornelissen IMHA, Jansen KFJ, et al. Antigen expression of metastasizing and non-metastasizing human melanoma cell lines xenografted into nude mice. Clin Exp Metastasis 1991;9: 259-72.
26. Luca M, Hunt B, Bucana CD, et al. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 1993;3:35-41.
27. Herlyn D, Adachi K, Koprowski H, Herlyn M. Experimental model of human melanoma metastases. Cancer Treat Res 1991;54:105-18.
28. Hsu M-Y, Meier F, Herlyn M. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 2002;70:522-36.
29. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
30. Herbert CA, Baker JB. Interleukin-8: a review. Cancer Invest 1993;11:743-50.
31. Kim SJ, Uehara H, Karashima T, et al. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 2001; 3:33-42.
32. Li A, Dubey S, Varney ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-76.
33. Pantschenko AG, Pushkar I, Anderson KH, et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 2003;23:269-84.
34. Weinreich DM, Elaraj DM, Puhlmann M, et al. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice. Cancer Res 2003;63:5957-61.
35. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 2003;100:2645-50.
36. Mattie S, Colombo MP, Melani C, et al. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1995;56:853-7.
37. Zhu H, Kleeff J, Friess H, et al. Epiregulin is upregulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem Biophys Res Commun 2000;273:1019-24.
38. Kumar K, Kobayashi T, Warner GM, et al. A novel immediate early response gene, IEX-1, is induced by ultraviolet radiation in human keratinocytes. Biochem Biophys Res Commun 1998;253:336-41.
39. Walker RA, Wooley DE. Immunolocalization studies of matrix metalloproteinases-1, -2 and -3 in human melanoma. Virchows Arch 1999;435:574-9.
40. Rennekampff HO, Hansbrough JF, Kiessig V, et al. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000;93:41-54.
41. Schadendorf D, Moller A, Algermissen B, et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993;151:2667-75.
42. Singh RK, Gutman M, Radinsky R, et al. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54:3242-7.
43. Wang JM, Taraboletti G, Matsushima K, et al. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/IL-8. Biochem Biophys Res Commun 1990;169:165-70.
44. Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol Cell Biol 1997; 17:4015-23.
45. Gutman M, Singh RK, Xie K, et al. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995;55:2470-5.
46. Luan J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance on the constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997; 62:588-97.
47. Takamori H, Oades ZG, Hoch OC, et al. Autocrine growth effect of IL-8 and GROα on a human pancreatic cancer cell line, Capan-1. Pancreas 2000;21:52-6.
48. Leek RD, Lewis CE, Whitehouse R, et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9.
49. Pantschenko AG, Pushkar I, Anderson KH, et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 2003;23:269-84.
50. Nozaki S, Sledge GW Jr, Nakshatri H. Cancer cell-derived interleukin 1α contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun 2000;275:60-2.